Remote Ischaemic Conditioning in STEMI Patients in Sub-Saharan AFRICA: Rationale and Study Design for the RIC-AFRICA Trial.
Kishal LukhnaDerek J HausenloyAbdelbagi Sidahmed AliAbdullah BajaberAlistair CalverArthur MutyabaAwad Abdalla MohamedBrian KiggunduChishala ChishalaEbrahim VariavaEhab Ali ElmakkiElijah OgolaEltayeb HamidEmmy OkelloIsam GaafarKeiran MwazoMakoali MakotokoMergan NaidooMohamed Elhadi AbdelhameedMotasim BadriNasief van der SchyffOmaima AbozaidPaul XafisSara GieszTrevor GouldWaldo WelgemoedMalcolm WalkerMpiko NtsekheDerek M YellonPublished in: Cardiovascular drugs and therapy (2021)
The RIC-AFRICA trial will determine whether RIC can reduce rates of death and heart failure in higher-risk sub-optimally reperfused STEMI patients, thereby providing a low-cost, non-invasive therapy for improving health outcomes.